CAR-T cells are made from a patient’s own immune cells, altered so that they specifically recognize and kill the patient’s cancer cells. They are effe…
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing compa…
Most T cell acute lymphoblastic leukemia (T-ALL) patients respond to chemotherapy, however many relapse with limited therapy options. To address this …
Our research consortium of diagnostic, translational and clinical researchers will undertake an integrated and novel exploration of the immune and gen…
By Abby Henry, Oncology Content Manager, PearlPoint Cancer Support
For many people, pets feel like a part of the family. After a cancer diagnosis, pets can offer many benefits. Benefits include: companionship, improve…
no-float col-12 View full multimedia release here. …
News Release
This accredited CE activity is intended for social workers, nurses, and other healthcare professionals involved in the care of patients with hematolog…
Education Resources
Table of contents:Predisposing Factors to LeukemiaLeukemia CausesGenetic MutationsIs Leukemia Hereditary?Causes of Leukemia in AdultsCauses of Leukemi…
SUMMERLIN, Nev., Dec. 14, 2021 - Secura Bio, Inc., an integrated pharmaceutical company dedicated to the worldwide development and commercialization o…
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
In July 2012, LLS began its partnership with Constellation to support three first-in-human Phase 1 clinical trials for blood cancer patients and is cu…
For the final installment of this series focusing on myeloma research, we will review advances in immunotherapies for myeloma. The most exciting curre…
In this project, we will test an innovative therapy called CAR T-cell therapy for children with a type of cancer called AML. In the laboratory, we hav…
The FDA approval will benefit children and adults with acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). Rye Brook, N.Y., January 28…
The FDA continues to expand availability of breakthrough CAR T-cell immunotherapy to benefit more blood cancer patientsRye Brook, N.Y., May 31, 2024 –…
News Release
The FDA approval will benefit children and adults with acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). Rye Brook, N.Y., January 28…
Education Resources
The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…
News Release
Part of the The Caregiver Workbook, which provides information for caregivers of adult patients.
Caregivers may order a copy of the full workbook by calling (800) 955-4572.
Part of the The Caring for Kids And Adolescents with Blood Cancer workbook, which provides information for caregivers of child and adolescent patients.
Caregivers may order a copy of the full workbook by calling (800) 955-4572.
This fact sheet provides information about oral treatment adherence, including tips and resources to help you remember to take your medications.
This fact sheet provides information about biomarker testing, which offers a way to look for genes, proteins, and other substances that can provide information about cancer.
Also available in Spanish.
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.